Bristol-Myers Squibb
Portfolio and financial intelligence platform that unified BMS's fragmented data landscape into a single source of truth — powering faster, more confident decisions across pipeline, finance, and operations.
$2.1B+
Portfolio value tracked in real time
40%
Faster quarterly reporting cycles
12+
Systems integrated into one platform
Dashboards Delivered
Portfolio Value Dashboard
Power BI dashboard consolidating asset NPV, licensing revenue, and R&D ROI across all therapeutic areas.
Executive Financial Reporting
Net Revenue
$11.2B
R&D Investment
$4.8B
Operating Margin
31.4%
EPS Growth
+9.2%
Tableau suite powering quarterly and annual financial reporting for executive leadership and the board.
AI Compound Prioritization
Azure ML model ranking pipeline compounds by commercial potential, scientific risk, and strategic fit.
Systems Integration Hub
Power BI integration layer unifying SAP, Veeva, and LIMS data into a single governed analytics platform.
Key Deliverables
- Enterprise portfolio dashboard consolidating pipeline asset value, licensing revenue, and R&D investment ROI
- Tableau financial intelligence suite for quarterly and annual reporting to executive leadership and board
- Power BI integration dashboard unifying data from SAP, Veeva, and internal LIMS systems
- AI-powered compound prioritization tool ranking pipeline assets by commercial potential and scientific risk
- Predictive analytics model forecasting therapeutic area revenue over 5-year horizons
- Automated KPI alerting system notifying stakeholders of threshold breaches in real time
Technology Stack
Power BI
Enterprise integration dashboards
Tableau
Executive financial reporting
Azure ML
Predictive analytics & AI
SAP Integration
ERP data pipelines
Veeva Vault
Clinical data connectivity
Snowflake
Cloud data warehousing
Looking for a similar solution?
Let's discuss how we can build the right tools for your organization.
Get in Touch